Stitch Fix, Inc. (SFIX) Guidance & Earnings Results

On 2026-09-23 Stitch Fix, Inc. mixed guidance: "FY2027 revenue $1.310-1.360B (-2.8% to +0.9% YoY); adjusted EBITDA $27-42M (2.1-3.1% margin); gross margin 43-44%. Q1 FY2027 revenue $323-328M (-5.6% to -4.1% YoY); adjusted EBITDA $3-6M (0.9-1.8%…" — from its own filing, as read by EquiReason.

Source: SEC EDGAR filings · figures as of 2026-08-01 · read by EquiReason

SFIXStitch Fix, Inc.Follow SFIX — free

Apparel Retail · Consumer Cyclical

—

Price chart with a free account

Market cap: 342.0M
P/E TTM: —
Dividend yield: —
52-week: —
Next earnings: 2 Dec, in 39 days

What management guided

each earnings 8-K · figures checked against the filing text

Release	Direction	What they said
23 Sep 26	Mixed	FY2027 revenue $1.310-1.360B (-2.8% to +0.9% YoY); adjusted EBITDA $27-42M (2.1-3.1% margin); gross margin 43-44%. Q1 FY2027 revenue $323-328M (-5.6% to -4.1% YoY); adjusted EBITDA $3-6M (0.9-1.8% margin).
10 Jun 26	Raised	Q4 FY2026 revenue guidance $322M-$327M; FY2026 revenue guidance $1.346B-$1.351B. · full year
11 Mar 26	Reaffirmed	Q3 revenue $330-335M (1.5-3.1% YoY), Adj EBITDA $7-10M; FY revenue $1.33-1.35B (5.0-6.5% YoY), Adj EBITDA $42-50M · full year
4 Dec 25	Raised	Q2 FY2026 revenue guidance $335M-$340M (7.3%-8.9% YoY), FY2026 revenue guidance $1.32B-$1.35B (4.2%-6.5% YoY)
24 Sep 25	Raised	Q1 FY2026 revenue $333-338M (+4.4-6.0% YoY); FY2026 revenue $1.28-1.33B (+1-5% YoY)

Stitch Fix, Inc. — questions

What guidance did Stitch Fix, Inc. give?: On 2026-09-23: "FY2027 revenue $1.310-1.360B (-2.8% to +0.9% YoY); adjusted EBITDA $27-42M (2.1-3.1% margin); gross margin 43-44%. Q1 FY2027 revenue $323-328M (-5.6% to -4.1% YoY); adjusted EBITDA $3-6M (0.9-1.8% margin)."
When does Stitch Fix, Inc. report earnings?: Stitch Fix, Inc.'s next earnings report is expected on 2026-12-02.

Every figure on this page comes from Stitch Fix, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.

Important information. Figures on this page are taken from filings submitted to the U.S. Securities and Exchange Commission (SEC) and processed automatically by EquiReason. They may contain errors, omissions or delays, and EquiReason makes no representation or warranty as to their accuracy, completeness or timeliness. Always verify figures against the original filing on SEC EDGAR before relying on them.

This page is provided for general information and educational purposes only. It does not constitute investment, financial, legal or tax advice, and it is not a recommendation or an offer to buy, sell or hold any security. It does not take into account your objectives, financial situation or needs. Past performance does not guarantee future results; any reliance on this information is at your own risk. See our Disclaimer and Risk Disclosure.